75 related articles for article (PubMed ID: 24858819)
21. Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiation.
Fukushima S; Yoshida A; Honda K; Maeshima AM; Narita Y; Yamada T; Shibui S; Tsuda H
Brain Tumor Pathol; 2014 Jan; 31(1):11-6. PubMed ID: 23504125
[TBL] [Abstract][Full Text] [Related]
22. CD9 expression in solid non-neuroepithelial tumors and infiltrative astrocytic tumors.
Kawashima M; Doh-ura K; Mekada E; Fukui M; Iwaki T
J Histochem Cytochem; 2002 Sep; 50(9):1195-203. PubMed ID: 12185197
[TBL] [Abstract][Full Text] [Related]
23. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Koga K; Todaka T; Morioka M; Hamada J; Kai Y; Yano S; Okamura A; Takakura N; Suda T; Ushio Y
Cancer Res; 2001 Aug; 61(16):6248-54. PubMed ID: 11507079
[TBL] [Abstract][Full Text] [Related]
24. Expression of the Ets-1 proto-oncogene correlates with malignant potential in human astrocytic tumors.
Kitange G; Kishikawa M; Nakayama T; Naito S; Iseki M; Shibata S
Mod Pathol; 1999 Jun; 12(6):618-26. PubMed ID: 10392639
[TBL] [Abstract][Full Text] [Related]
25. Collaborative overexpression of matrix metalloproteinase-1 and vascular endothelial growth factor-C predicts adverse prognosis in patients with gliomas.
Xu Y; Zhong Z; Yuan J; Zhang Z; Wei Q; Song W; Chen H
Cancer Epidemiol; 2013 Oct; 37(5):697-702. PubMed ID: 23870768
[TBL] [Abstract][Full Text] [Related]
26. Plakoglobin (gamma-catenin) has TCF/LEF family-dependent transcriptional activity in beta-catenin-deficient cell line.
Maeda O; Usami N; Kondo M; Takahashi M; Goto H; Shimokata K; Kusugami K; Sekido Y
Oncogene; 2004 Jan; 23(4):964-72. PubMed ID: 14661054
[TBL] [Abstract][Full Text] [Related]
27. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
Jung HC; Kim K
Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
[TBL] [Abstract][Full Text] [Related]
28. Diversity of LEF/TCF action in development and disease.
Arce L; Yokoyama NN; Waterman ML
Oncogene; 2006 Dec; 25(57):7492-504. PubMed ID: 17143293
[TBL] [Abstract][Full Text] [Related]
29. Microvessel density in brain tumors.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
[TBL] [Abstract][Full Text] [Related]
30. Brief report: Oct4 and canonical Wnt signaling regulate the cardiac lineage factor Mesp1 through a Tcf/Lef-Oct4 composite element.
Li Y; Yu W; Cooney AJ; Schwartz RJ; Liu Y
Stem Cells; 2013 Jun; 31(6):1213-7. PubMed ID: 23417899
[TBL] [Abstract][Full Text] [Related]
31. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
[TBL] [Abstract][Full Text] [Related]
32. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
33. TCF-1 and LEF-1 act upstream of Th-POK to promote the CD4(+) T cell fate and interact with Runx3 to silence Cd4 in CD8(+) T cells.
Steinke FC; Yu S; Zhou X; He B; Yang W; Zhou B; Kawamoto H; Zhu J; Tan K; Xue HH
Nat Immunol; 2014 Jul; 15(7):646-656. PubMed ID: 24836425
[TBL] [Abstract][Full Text] [Related]
34. Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas.
Waha A; Baumann A; Wolf HK; Fimmers R; Neumann J; Kindermann D; Astrahantseff K; Blümcke I; von Deimling A; Schlegel U
J Neurosurg; 1996 Oct; 85(4):634-41. PubMed ID: 8814167
[TBL] [Abstract][Full Text] [Related]
35. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
Geiger KD; Stoldt P; Schlote W; Derouiche A
Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
[TBL] [Abstract][Full Text] [Related]
36. Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway.
Mi K; Johnson GV
J Cell Biochem; 2005 May; 95(2):328-38. PubMed ID: 15778991
[TBL] [Abstract][Full Text] [Related]
37. SALL4 is directly activated by TCF/LEF in the canonical Wnt signaling pathway.
Böhm J; Sustmann C; Wilhelm C; Kohlhase J
Biochem Biophys Res Commun; 2006 Sep; 348(3):898-907. PubMed ID: 16899215
[TBL] [Abstract][Full Text] [Related]
38. N-cadherin, beta-catenin and connexin 43 expression in astrocytic tumours of various grades.
Reszec J; Szkudlarek M; Hermanowicz A; Bernaczyk PS; Mariak Z; Chyczewski L
Histol Histopathol; 2015 Mar; 30(3):361-71. PubMed ID: 25386667
[TBL] [Abstract][Full Text] [Related]
39. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
[TBL] [Abstract][Full Text] [Related]
40. Metabolic patterns in malignant gliomas.
Meixensberger J; Herting B; Roggendorf W; Reichmann H
J Neurooncol; 1995; 24(2):153-61. PubMed ID: 7562002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
